Register for a live broadcast to learn more about TRODELVY (sacituzumab govitecan-hziy) with Dr. Hope S. Rugo

General Discussions

ICYMI: 5 Most Recent FDA Approvals, June 23, 2020

By Brielle Benyon
PUBLISHED WEDNESDAY, DECEMBER 31, 1969


As spring turns to summer, the FDA is not slowing down in approving drugs in the oncology space – some for very specific cancer types, and others (such as the recent approval of pembrolizumab) for a whole range of solid tumors that have a high mutational burden.

In case you missed it, here is a list of the 5 most recent FDA approvals:
 
Sign up for Oncology Nursing News emails and never miss an approval or the latest in the field of oncology nursing.
 
Start a discussion
You must log in to use this feature, please click here to login.
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.